Impact of vitamin D supplementation on arterial vasomotion, stiffness and endothelial biomarkers in chronic kidney disease patients

PLoS ONE

Volumn 9, Issue 3, 2014, Pages

  Chitalia, Nihil ^a,b   Ismail, Tuan ^b   Tooth, Laura ^a   Boa, Frances ^a   Hampson, Geeta ^c   Goldsmith, David ^c   Kaski, Juan Carlos ^b   Banerjee, Debasish ^a,b  

^a ST GEORGE'S UNIVERSITY HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

^b ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

^c GUY'S AND ST THOMAS' NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

25 HYDROXYVITAMIN D; BIOLOGICAL MARKER; C REACTIVE PROTEIN; CALCIUM; COLECALCIFEROL; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; FIBROBLAST GROWTH FACTOR 23; INTERCELLULAR ADHESION MOLECULE 1; PARATHYROID HORMONE; VASCULAR CELL ADHESION MOLECULE 1; VON WILLEBRAND FACTOR; 25-HYDROXYVITAMIN D; FIBROBLAST GROWTH FACTOR; SELE PROTEIN, HUMAN; VITAMIN D;

ADULT; ARTERIAL STIFFNESS; ARTERIAL VASOMOTION; ARTICLE; AUGMENTATION INDEX; BLOOD PRESSURE; BLOOD VESSEL FUNCTION; CALCIUM BLOOD LEVEL; CHRONIC KIDNEY DISEASE; CLINICAL ARTICLE; CLINICAL TRIAL; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; MALE; PULSE WAVE; VASCULAR ENDOTHELIUM; VASODILATATION; VITAMIN BLOOD LEVEL; VITAMIN D DEFICIENCY; ADOLESCENT; AGED; ANALOGS AND DERIVATIVES; BLOOD; CHRONIC KIDNEY FAILURE; COMPLICATION; DIET SUPPLEMENTATION; DIET THERAPY; DRUG EFFECTS; MIDDLE AGED; PATHOPHYSIOLOGY; VERY ELDERLY;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; CALCIUM; DIETARY SUPPLEMENTS; E-SELECTIN; FEMALE; FIBROBLAST GROWTH FACTORS; HUMANS; INTERCELLULAR ADHESION MOLECULE-1; MALE; MIDDLE AGED; PARATHYROID HORMONE; PULSE WAVE ANALYSIS; RENAL INSUFFICIENCY, CHRONIC; VASCULAR CELL ADHESION MOLECULE-1; VASCULAR STIFFNESS; VASODILATION; VITAMIN D; VITAMIN D DEFICIENCY;

EID: 84898646329     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0091363     Document Type: Article

References (47)

1. Go AS, Chertow GM, Fan D, McCulloch CE, Hsu CY (2004) Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med 351: 1296-1305
2. Tonelli M, Muntner P, Lloyd A, Manns BJ, Klarenbach S, et al. (2012) Risk of coronary events in people with chronic kidney disease compared with those with diabetes: a population-level cohort study. Lancet 380: 807-814
3. Halcox JP, Schenke WH, Zalos G, Mincemoyer R, Prasad A, et al. (2002) Prognostic value of coronary vascular endothelial dysfunction. Circulation 106: 653-658 (Pubitemid 34851922)
4. Suwaidi JA, Hamasaki S, Higano ST, Nishimura RA, Holmes DR Jr, et al (2000) Long-term follow-up of patients with mild coronary artery disease and endothelial dysfunction. Circulation 101: 948-954 (Pubitemid 30131694)
5. Recio-Mayoral A, Banerjee D, Streather C, Kaski JC (2011) Endothelial dysfunction, inflammation and atherosclerosis in chronic kidney disease-a cross-sectional study of predialysis, dialysis and kidney-transplantation patients. Atherosclerosis 216: 446-451
6. Deanfield J, Donald A, Ferri C, Giannattasio C, Halcox J, et al. (2005) Endothelial function and dysfunction. Part I: Methodological issues for assessment in the different vascular beds: a statement by the Working Group on Endothelin and Endothelial Factors of the European Society of Hypertension. J Hypertens 23: 7-17 (Pubitemid 40128972)
7. Anderson TJ, Uehata A, Gerhard MD, Meredith IT, Knab S, et al. (1995) Close relation of endothelial function in the human coronary and peripheral circulations. J Am Coll Cardiol 26: 1235-1241
8. Stam F, van GC, Becker A, Dekker JM, Heine RJ, et al. (2006) Endothelial dysfunction contributes to renal function-associated cardiovascular mortality in a population with mild renal insufficiency: the Hoorn study. J Am Soc Nephrol 17: 537-545
9. Yeboah J, Folsom AR, Burke GL, Johnson C, Polak JF, et al. (2009) Predictive value of brachial flow-mediated dilation for incident cardiovascular events in a population-based study: the multi-ethnic study of atherosclerosis. Circulation 120: 502-509
10. Bae JH, Bassenge E, Lee HJ, Park KR, Park CG, et al (2001) Impact of postprandial hypertriglyceridemia on vascular responses in patients with coronary artery disease: effects of ACE inhibitors and fibrates. Atherosclerosis 158: 165-171
11. Sidhu JS, Cowan D, Kaski JC (2004) Effects of rosiglitazone on endothelial function in men with coronary artery disease without diabetes mellitus. Am J Cardiol 94: 151-156 (Pubitemid 38902860)
12. Timimi FK, Ting HH, Haley EA, Roddy MA, Ganz P, et al. (1998) Vitamin C improves endothelium-dependent vasodilation in patients with insulin-dependent diabetes mellitus. J Am Coll Cardiol 31: 552-557 (Pubitemid 28144120)
13. Suessenbacher A, Frick M, Alber HF, Barbieri V, Pachinger O, et al. (2006) Association of improvement of brachial artery flow-mediated vasodilation with cardiovascular events. Vasc Med 11: 239-244 (Pubitemid 46470502)
14. Chitalia N, Recio-Mayoral A, Kaski JC, Banerjee D (2012) Vitamin D deficiency and endothelial dysfunction in non-dialysis chronic kidney disease patients. Atherosclerosis 220: 265-268
15. Pilz S, Tomaschitz A, Friedl C, Amrein K, Drechsler C, et al (2011) Vitamin D status and mortality in chronic kidney disease. Nephrol Dial Transplant 26: 3603-3609
16. Borges AC, Feres T, Vianna LM, Paiva TB (1999) Effect of cholecalciferol treatment on the relaxant responses of spontaneously hypertensive rat arteries to acetylcholine. Hypertension 34: 897-901 (Pubitemid 29501320)
17. Wong MS, Delansorne R, Man RY, Svenningsen P, Vanhoutte PM (2010) Chronic treatment with vitamin D lowers arterial blood pressure and reduces endothelium-dependent contractions in the aorta of the spontaneously hypertensive rat. Am J Physiol Heart Circ Physiol 299: H1226-H1234
18. Sugden JA, Davies JI, Witham MD, Morris AD, Struthers AD (2008) Vitamin D improves endothelial function in patients with Type 2 diabetes mellitus and low vitamin D levels. Diabet Med 25: 320-325 (Pubitemid 351322698)
19. Gutierrez OM, Mannstadt M, Isakova T, Rauh-Hain JA, Tamez H,et al (2008) Fibroblast growth factor 23 and mortality among patients undergoing hemodialysis. N Engl J Med 359: 584-592
20. Kanbay M, Huddam B, Azak A, Solak Y, Kadioglu GK, et al (2011) A randomized study of allopurinol on endothelial function and estimated glomular filtration rate in asymptomatic hyperuricemic subjects with normal renal function. Clin J Am Soc Nephrol 6: 1887-1894
21. Wolf M, Molnar MZ, Amaral AP, Czira ME, Rudas A, et al. (2011) Elevated fibroblast growth factor 23 is a risk factor for kidney transplant loss and mortality. J Am Soc Nephrol 22: 956-966
22. Sidhu JS, Newey VR, Nassiri DK, Kaski JC (2002) A rapid and reproducible on line automated technique to determine endothelial function. Heart 88: 289-292 (Pubitemid 34913516)
23. Chandra P, Binongo JN, Ziegler TR, Schlanger LE, Wang W,et al (2008) Cholecalciferol (vitamin D3) therapy and vitamin D insufficiency in patients with chronic kidney disease: a randomized controlled pilot study. Endocr Pract 14: 10-17
24. Leventis P, Kiely PD (2009) The tolerability and biochemical effects of high-dose bolus vitamin D2 and D3 supplementation in patients with vitamin D insufficiency. Scand J Rheumatol 38: 149-153
25. Fraser WD, Milan AM (2013) Vitamin D assays: past and present debates, difficulties, and developments. Calcif Tissue Int 92: 118-127
26. Procsal DA, Okamura WH, Norman AW (1975) Structural requirements for the interaction of 1 alpha, 25-(OH) 2- vitiamin D3 with its chick interestinal receptor system. J Biol Chem 250: 8382-8388
27. Lou YR, Molnar F, Perakyla M, Qiao S, Kalueff AV, et al (2010) 25-Hydroxyvitamin D(3) is an agonistic vitamin D receptor ligand. J Steroid Biochem Mol Biol 118: 162-170
28. Dobnig H, Pilz S, Scharnagl H, Renner W, Seelhorst U, et al. (2008) Independent association of low serum 25-hydroxyvitamin d and 1,25-dihydroxyvitamin d levels with all-cause and cardiovascular mortality. Arch Intern Med 168: 1340-1349 (Pubitemid 351930842)
29. Kestenbaum B, Katz R, de Boer I, Hoofnagle A, Sarnak MJ, et al S (2011) Vitamin D, parathyroid hormone, and cardiovascular events among older adults. J Am Coll Cardiol 58: 1433-1441
30. Drechsler C, Verduijn M, Pilz S, Dekker FW, Krediet RT, et al (2011) Vitamin D status and clinical outcomes in incident dialysis patients: results from the NECOSAD study. Nephrol Dial Transplant 26: 1024-1032
31. Yilmaz MI, Stenvinkel P, Sonmez A, Saglam M, Yaman H, et al. (2011) Vascular health, systemic inflammation and progressive reduction in kidney function; clinical determinants and impact on cardiovascular outcomes. Nephrol Dial Transplant 26: 3537-3543
32. Harris RA, Pedersen-White J, Guo DH, Stallmann-Jorgensen IS, Keeton D, et al. (2011) Vitamin D3 supplementation for 16 weeks improves flow-mediated dilation in overweight African-American adults. Am J Hypertens 24: 557-562
33. Witham MD, Dove FJ, Sugden JA, Doney AS, Struthers AD (2012) The effect of vitamin D replacement on markers of vascular health in stroke patients - a randomised controlled trial. Nutr Metab Cardiovasc Dis 22: 864-870
34. Gepner AD, Ramamurthy R, Krueger DC, Korcarz CE, Binkley N, et al. (2012) A prospective randomized controlled trial of the effects of vitamin D supplementation on cardiovascular disease risk. PLoS One 7: e36617
35. Shab-Bidar S, Neyestani TR, Djazayery A, Eshraghian MR, Houshiarrad A, et al (2011) Regular consumption of vitamin D-fortified yogurt drink (Doogh) improved endothelial biomarkers in subjects with type 2 diabetes: a randomized double-blind clinical trial. BMC Med 9: 125
36. Witham MD, Dove FJ, Dryburgh M, Sugden JA, Morris AD, et al. (2010) The effect of different doses of vitamin D(3) on markers of vascular health in patients with type 2 diabetes: a randomised controlled trial. Diabetologia 53: 2112-2119
37. Witham MD, Dove FJ, Khan F, Lang CC, Belch JJ, et al. (2012) Effects of Vitamin D supplementation on markers of vascular function after myocardial infarction-A randomised controlled trial. Int J Cardiol.
38. Sokol SI, Srinivas V, Crandall JP, Kim M, Tellides G, et al. (2012) The effects of vitamin D repletion on endothelial function and inflammation in patients with coronary artery disease. Vasc Med 17: 394-404
39. Herbelin A, Urena P, Nguyen AT, Zingraff J, scamps-Latscha B (1991) Elevated circulating levels of interleukin-6 in patients with chronic renal failure. Kidney Int 39: 954-960
40. scamps-Latscha B, Herbelin A, Nguyen AT, Zingraff J, Jungers P, et al 1994) Immune system dysregulation in uremia. Semin Nephrol 14: 253-260
41. Barrat FJ, Cua DJ, Boonstra A, Richards DF, Crain C, et al. (2002) In vitro generation of interleukin 10-producing regulatory CD4 (+) T cells is induced by immunosuppressive drugs and inhibited by T helper type 1 (Th1)- and Th2-inducing cytokines. J Exp Med 195: 603-616 (Pubitemid 34461505)
42. Froicu M, Weaver V, Wynn TA, McDowell MA, Welsh JE, et al. (2003) A crucial role for the vitamin D receptor in experimental inflammatory bowel diseases. Mol Endocrinol 17: 2386-2392 (Pubitemid 37542204)
43. Muller K, Bendtzen K (1996) 1,25-Dihydroxyvitamin D3 as a natural regulator of human immune functions. J Investig Dermatol Symp Proc 1: 68-71 (Pubitemid 126759345)
44. Faul C, Amaral AP, Oskouei B, Hu MC, Sloan A, et al. (2011) FGF23 induces left ventricular hypertrophy. J Clin Invest 121: 4393-4408
45. Gutierrez OM (2010) Fibroblast growth factor 23 and disordered vitamin D metabolism in chronic kidney disease: updating the "trade-off" hypothesis. Clin J Am Soc Nephrol 5: 1710-1716
46. Turner C, Dalton N, Inaoui R, Fogelman I, Fraser WD, et al. (2013) Effect of a 300 000-IU Loading Dose of Ergocalciferol (Vitamin D2) on Circulating 1,25(OH)2-Vitamin D and Fibroblast Growth Factor-23 (FGF-23) in Vitamin D Insufficiency. J Clin Endocrinol Metab
47. Uzum AK, Salman S, Telci A, Boztepe H, Tanakol R, et al (2010) Effects of vitamin D replacement therapy on serum FGF23 concentrations in vitamin D-deficient women in short term. Eur J Endocrinol 163: 825-831